RxDoctor Payments Data

Heather Clawges, MD

Pediatrics · Ronceverte, WVNPI 1316027410

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 68.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $10,939 and has fallen 84.5% since, to $1,695 in 2025. Among pediatrics clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,266in general payments, 2019–2025

Across 106 payments — averaging $162.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$12K
  • Resmed Corp$5K
  • Harmony Biosciences LLC$285
  • Inspire Medical Systems, Inc.$120
  • Axsome Therapeutics, Inc.$111
  • ZOLL Respicardia, Inc.$84
  • plus $66 from 3 others

What the payments were for

  • Consulting fees$4,83828%
  • Speaking & faculty fees$9,34054%
  • Travel & lodging$1,0056%
  • Food & beverage$1,6289%
  • Education$4563%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,266 in reported general payments places this provider in the 95th percentile of 207 pediatrics providers in West Virginia.

See all pediatrics providers in West Virginia

Medicare billing

Part B allowed, 2024
$54,659
Medicare patients
438
Services billed
702

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sodium Oxybate12$191,068
XywavSodium,calcium,mag,pot Oxybate11$176,151
SunosiSolriamfetol Hcl30$30,340
BelsomraSuvorexant19$9,081
Modafinil109$3,552
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate18$2,046
Dextroamphetamine Sulfate20$1,875
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine52$1,709
Armodafinil39$1,263
Methylphenidate Hcl33$908
Temazepam35$503
Mirtazapine12$288
Clonazepam48$234
Gabapentin31$225
Eszopiclone18$215

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Axsome Therapeutics, Inc.Sunosi$111$30,34030 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 207 pediatrics providers in West Virginia.

Other pediatrics in Ronceverte

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →